Nasopharyngeal carcinoma secondary prevention: Difference between revisions

Jump to navigation Jump to search
Line 13: Line 13:
After treatment, patients with nasopharyngeal carcinoma should follow up for prevention of second malignancy. Follow up includes:
After treatment, patients with nasopharyngeal carcinoma should follow up for prevention of second malignancy. Follow up includes:
*Physical exam
*Physical exam
**Every 1-3 months for 1st year after treatment
**Every 2-6 months for 2nd year after treatment
**Every 4-8 months for 3-5 years after treatment
**Every year after 5 years
*Nasendoscopy
*Nasendoscopy
===Scanning===
*CT Scan
*CT Scan
*MRI
*MRI
Scans are performed at routine intervals as follows:
Scans are performed at routine intervals as follows:
*3-6 months after radiotherapy
*Baseline scanning is done in 3-6 months after treatment, further scans are scheduled based on finding of physical exam and symptoms experienced by the patient
*Every 6 months afterwards until 5 years
*Scanning for asymptomatic patients is not encouraged
*Every year after 5 years
===Thyroid hormone testing===
Thyroid stimulating hormone testing every 12 months if neck is exposed to radiation therapy
===Dental screening===
Only implicated if oral cavity is exposed to radiations


==References==
==References==

Revision as of 12:22, 29 September 2015

Nasopharyngeal carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Nasopharyngeal carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Nasopharyngeal carcinoma secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Nasopharyngeal carcinoma secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Nasopharyngeal carcinoma secondary prevention

CDC on Nasopharyngeal carcinoma secondary prevention

Nasopharyngeal carcinoma secondary prevention in the news

Blogs on Nasopharyngeal carcinoma secondary prevention

Directions to Hospitals Treating Nasopharyngeal carcinoma

Risk calculators and risk factors for Nasopharyngeal carcinoma secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]

Overview

EBV-associated antibodies may be helpful for secondary prevention of nasopharyngeal carcinoma.

Secondary Prevention

EBV-associated antibodies may be helpful for secondary prevention of nasopharyngeal carcinoma.

Follow up after treatment

After treatment, patients with nasopharyngeal carcinoma should follow up for prevention of second malignancy. Follow up includes:

  • Physical exam
    • Every 1-3 months for 1st year after treatment
    • Every 2-6 months for 2nd year after treatment
    • Every 4-8 months for 3-5 years after treatment
    • Every year after 5 years
  • Nasendoscopy

Scanning

  • CT Scan
  • MRI

Scans are performed at routine intervals as follows:

  • Baseline scanning is done in 3-6 months after treatment, further scans are scheduled based on finding of physical exam and symptoms experienced by the patient
  • Scanning for asymptomatic patients is not encouraged

Thyroid hormone testing

Thyroid stimulating hormone testing every 12 months if neck is exposed to radiation therapy

Dental screening

Only implicated if oral cavity is exposed to radiations

References


Template:WikiDoc Sources